CN101138741A - A kind of ruthenium catalyst supported by ionic liquid containing pyridine ligand and its preparation - Google Patents
A kind of ruthenium catalyst supported by ionic liquid containing pyridine ligand and its preparation Download PDFInfo
- Publication number
- CN101138741A CN101138741A CNA2007100469902A CN200710046990A CN101138741A CN 101138741 A CN101138741 A CN 101138741A CN A2007100469902 A CNA2007100469902 A CN A2007100469902A CN 200710046990 A CN200710046990 A CN 200710046990A CN 101138741 A CN101138741 A CN 101138741A
- Authority
- CN
- China
- Prior art keywords
- ionic liquid
- pyridine ligand
- organic solvent
- ruthenium catalyst
- catalyst
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title claims abstract description 81
- 239000002608 ionic liquid Substances 0.000 title claims abstract description 62
- 239000003054 catalyst Substances 0.000 title claims abstract description 51
- 239000003446 ligand Substances 0.000 title claims abstract description 46
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 title claims abstract description 40
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 title claims abstract description 39
- 229910052707 ruthenium Inorganic materials 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 61
- 238000006243 chemical reaction Methods 0.000 claims abstract description 31
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims abstract description 12
- GCNTZFIIOFTKIY-UHFFFAOYSA-N 4-hydroxypyridine Chemical compound OC1=CC=NC=C1 GCNTZFIIOFTKIY-UHFFFAOYSA-N 0.000 claims abstract description 5
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 33
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 27
- 239000003960 organic solvent Substances 0.000 claims description 25
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 22
- 239000007788 liquid Substances 0.000 claims description 15
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- PNPBGYBHLCEVMK-UHFFFAOYSA-N benzylidene(dichloro)ruthenium;tricyclohexylphosphanium Chemical compound Cl[Ru](Cl)=CC1=CC=CC=C1.C1CCCCC1[PH+](C1CCCCC1)C1CCCCC1.C1CCCCC1[PH+](C1CCCCC1)C1CCCCC1 PNPBGYBHLCEVMK-UHFFFAOYSA-N 0.000 claims description 12
- FCDPQMAOJARMTG-UHFFFAOYSA-M benzylidene-[1,3-bis(2,4,6-trimethylphenyl)imidazolidin-2-ylidene]-dichlororuthenium;tricyclohexylphosphanium Chemical compound C1CCCCC1[PH+](C1CCCCC1)C1CCCCC1.CC1=CC(C)=CC(C)=C1N(CCN1C=2C(=CC(C)=CC=2C)C)C1=[Ru](Cl)(Cl)=CC1=CC=CC=C1 FCDPQMAOJARMTG-UHFFFAOYSA-M 0.000 claims description 12
- 229910052757 nitrogen Inorganic materials 0.000 claims description 11
- 239000011986 second-generation catalyst Substances 0.000 claims description 11
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 claims description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- -1 glyoxaline compound Chemical class 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 239000005457 ice water Substances 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 230000035484 reaction time Effects 0.000 claims description 4
- 239000011985 first-generation catalyst Substances 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 3
- 229910020808 NaBF Inorganic materials 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000003944 halohydrins Chemical class 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims 9
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 claims 2
- RKHQZMOCQHXUBC-UHFFFAOYSA-N phenol;potassium Chemical compound [K].OC1=CC=CC=C1 RKHQZMOCQHXUBC-UHFFFAOYSA-N 0.000 claims 2
- 239000002131 composite material Substances 0.000 claims 1
- 238000002425 crystallisation Methods 0.000 claims 1
- 230000008025 crystallization Effects 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 239000002798 polar solvent Substances 0.000 abstract description 9
- 238000007152 ring opening metathesis polymerisation reaction Methods 0.000 abstract description 7
- 150000001298 alcohols Chemical class 0.000 abstract description 3
- 238000006116 polymerization reaction Methods 0.000 abstract description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 24
- 239000007787 solid Substances 0.000 description 23
- 125000003118 aryl group Chemical group 0.000 description 19
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- 239000000460 chlorine Substances 0.000 description 13
- 239000002904 solvent Substances 0.000 description 13
- 230000015572 biosynthetic process Effects 0.000 description 11
- 238000003786 synthesis reaction Methods 0.000 description 11
- 238000005160 1H NMR spectroscopy Methods 0.000 description 10
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- GIWQSPITLQVMSG-UHFFFAOYSA-N 1,2-dimethylimidazole Chemical compound CC1=NC=CN1C GIWQSPITLQVMSG-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000011984 grubbs catalyst Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- DTAQICDIDNVMJA-UHFFFAOYSA-M 1-dodecyl-2,3-dimethylimidazol-3-ium;bromide Chemical compound [Br-].CCCCCCCCCCCC[N+]=1C=CN(C)C=1C DTAQICDIDNVMJA-UHFFFAOYSA-M 0.000 description 1
- FAESVICFPRJZOH-UHFFFAOYSA-M 2-(2,3-dimethylimidazol-3-ium-1-yl)ethanol;chloride Chemical compound [Cl-].CC=1N(C)C=C[N+]=1CCO FAESVICFPRJZOH-UHFFFAOYSA-M 0.000 description 1
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 description 1
- SZIFAVKTNFCBPC-UHFFFAOYSA-N 2-chloroethanol Chemical compound OCCCl SZIFAVKTNFCBPC-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- ASIDMJNTHJYVQJ-UHFFFAOYSA-N bromo-dodecanol Chemical compound OCCCCCCCCCCCCBr ASIDMJNTHJYVQJ-UHFFFAOYSA-N 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 238000010550 living polymerization reaction Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 238000001225 nuclear magnetic resonance method Methods 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明涉及一种钌催化剂及其制备方法,特别涉及一种含吡啶配体的离子液体负载的钌催化剂及其制备方法,属于催化剂及其制备技术领域。将咪唑类离子液体与4-羟基吡啶反应得到含吡啶基团的咪唑类离子液体与[Ru]配位制得。制得的该钌催化剂由于含有离子液体部分而可以很好的溶解于极性溶剂特别是离子液体中,从而实现在纯离子液体中的开环易位聚合(ROMP)反应。该钌催化剂改善了现有的钌催化剂在极性溶剂中溶解性差的缺点,此催化剂可以溶解在极性溶剂如醇类、丙酮和离子液体中,进而实现在纯离子液体中的开环易位聚合反应,拓展了钌催化剂的应用范围。The invention relates to a ruthenium catalyst and a preparation method thereof, in particular to a ruthenium catalyst supported by an ionic liquid containing a pyridine ligand and a preparation method thereof, belonging to the technical field of catalyst and preparation thereof. The imidazole ionic liquid is reacted with 4-hydroxypyridine to obtain the imidazole ionic liquid containing pyridine group and coordinated with [Ru]. The prepared ruthenium catalyst can be well dissolved in a polar solvent, especially an ionic liquid, because it contains an ionic liquid part, thereby realizing a ring-opening metathesis polymerization (ROMP) reaction in a pure ionic liquid. The ruthenium catalyst improves the disadvantage of poor solubility in polar solvents of existing ruthenium catalysts, and the catalyst can be dissolved in polar solvents such as alcohols, acetone, and ionic liquids, thereby realizing ring-opening metathesis in pure ionic liquids The polymerization reaction expands the application scope of ruthenium catalyst.
Description
技术领域technical field
本发明涉及一种钌催化剂及其制备方法,特别涉及一种含吡啶配体的离子液体负载的钌催化剂及其制备方法,属于催化剂及其制备技术领域。The invention relates to a ruthenium catalyst and a preparation method thereof, in particular to a ruthenium catalyst supported by an ionic liquid containing a pyridine ligand and a preparation method thereof, belonging to the technical field of catalyst and preparation thereof.
背景技术Background technique
钌催化剂是开环易位聚合反应中影响单体聚合的重要因素。目前已有的Grubbs第一代和第二代催化剂由于具有良好的稳定性和官能团耐受性,可以进行活性聚合并得到结构明确的产物而成为广泛应用的催化剂。但Grubbs催化剂只在二氯甲烷、苯、甲苯等非极性溶剂中有良好的溶解性,在极性溶剂如醇类、水和离子液体中溶解性很差,而限制了其在极性溶剂中开环易位聚合(ROMP)反应的进行。Ruthenium catalyst is an important factor affecting monomer polymerization in ring-opening metathesis polymerization. The existing Grubbs first-generation and second-generation catalysts have become widely used catalysts due to their good stability and functional group tolerance, which can carry out living polymerization and obtain products with well-defined structures. But the Grubbs catalyst only has good solubility in nonpolar solvents such as methylene chloride, benzene, toluene, and has poor solubility in polar solvents such as alcohols, water and ionic liquids, and limits its use in polar solvents. in the ring-opening metathesis polymerization (ROMP) reaction.
发明内容Contents of the invention
本发明的目的在于克服目前已有的钌催化剂在极性溶剂中溶解性差的缺点,改善其在离子液体等极性溶剂中的溶解性,从而实现在纯离子液体环境中的聚合反应。The purpose of the present invention is to overcome the disadvantages of poor solubility of existing ruthenium catalysts in polar solvents, improve their solubility in polar solvents such as ionic liquids, so as to realize the polymerization reaction in a pure ionic liquid environment.
本发明的一种含吡啶配体的离子液体负载的钌催化剂的结构式如下:The structural formula of the ruthenium catalyst supported by a kind of ionic liquid containing pyridine ligand of the present invention is as follows:
上述式中,R1为BF4 -,PF6 -或CF3COO-;R2为H或甲基(-CH3);n是从2到12的自然数,[Ru]是Grubbs第一代催化剂或Grubbs第二代催化剂。In the above formula, R 1 is BF 4 - , PF 6 - or CF 3 COO - ; R 2 is H or methyl (-CH 3 ); n is a natural number from 2 to 12, [Ru] is the first generation of Grubbs Catalyst or Grubbs second generation catalyst.
当R1为BF4 -,R2为H,[Ru]为Grubbs第一代或Grubbs第二代催化剂,n=2时,所述的含吡啶配体的离子液体负载的钌催化剂为:When R 1 is BF 4 − , R 2 is H, [Ru] is Grubbs first-generation or Grubbs second-generation catalyst, and n=2, the ruthenium catalyst supported by an ionic liquid containing a pyridine ligand is:
当R1为BF4 -,R2为-CH3,[Ru]为Grubbs第一代或Grubbs第二代催化剂,n=2时,所述的含吡啶配体的离子液体负载的钌催化剂为:When R 1 is BF 4 - , R 2 is -CH 3 , [Ru] is Grubbs first-generation or Grubbs second-generation catalyst, and n=2, the ruthenium catalyst supported by an ionic liquid containing a pyridine ligand is :
当R1为PF6 -,R2为H,[Ru]为Grubbs第一代或Grubbs第二代催化剂,n=2时,所述的含吡啶配体的离子液体负载的钌催化剂为:When R 1 is PF 6 − , R 2 is H, [Ru] is Grubbs first-generation or Grubbs second-generation catalyst, and n=2, the ruthenium catalyst supported by an ionic liquid containing a pyridine ligand is:
当R1为PF6 -,R2为-CH3,[Ru]为Grubbs第一代或Grubbs第二代催化剂,n=2时,所述的含吡啶配体的离子液体负载的钌催化剂为:When R 1 is PF 6 - , R 2 is -CH 3 , [Ru] is Grubbs first-generation or Grubbs second-generation catalyst, and n=2, the ruthenium catalyst supported by an ionic liquid containing a pyridine ligand is :
当R1为CF3COO-,R2为H,[Ru]为Grubbs第一代或Grubbs第二代催化剂,n=2时,所述的含吡啶配体的离子液体负载的钌催化剂为:When R 1 is CF 3 COO - , R 2 is H, [Ru] is Grubbs first-generation or Grubbs second-generation catalyst, and n=2, the ruthenium catalyst supported by an ionic liquid containing a pyridine ligand is:
当R1为CF3COO-,R2为-CH3,[Ru]为Grubbs第一代或Grubbs第二代催化剂,n=2时,所述的含吡啶配体的离子液体负载的钌催化剂为:When R 1 is CF 3 COO - , R 2 is -CH 3 , [Ru] is Grubbs first-generation or Grubbs second-generation catalyst, n=2, the ruthenium catalyst supported by ionic liquid containing pyridine ligand for:
本发明的一种含吡啶配体的离子液体负载的钌催化剂的制备方法,合成路线为:A kind of preparation method of the ruthenium catalyst supported by the ionic liquid containing pyridine ligand of the present invention, synthetic route is:
上述式中,X=Cl,Br,R1为BF4 -,PF6 -或CF3COO-,R2为H或甲基(-CH3),Mt为Na或K,n是从2到12的自然数,[Ru]是Grubbs第一代催化剂或Grubbs第二代催化剂。In the above formula, X=Cl, Br, R 1 is BF 4 - , PF 6 - or CF 3 COO - , R 2 is H or methyl (-CH 3 ), M t is Na or K, n is from 2 Natural numbers to 12, [Ru] is Grubbs first-generation catalyst or Grubbs second-generation catalyst.
本发明的一种含吡啶配体的离子液体负载的钌催化剂的制备方法,具体按照下列顺序、步骤进行:A kind of preparation method of the ruthenium catalyst supported by the ionic liquid containing pyridine ligand of the present invention, specifically carry out according to following order, step:
第一步:合成结构式如下的离子液体:Step 1: Synthesize an ionic liquid with the following structural formula:
上述式中,R1为BF4 -,PF6 -或CF3COO-,R2为H或甲基(-CH3),n是从2到12的自然数。In the above formula, R 1 is BF 4 - , PF 6 - or CF 3 COO - , R 2 is H or methyl (-CH 3 ), and n is a natural number from 2 to 12.
(1)将咪唑类化合物与卤代醇X-(CH2)n-OH按照摩尔比1∶1~1∶1.2反应,在有机溶剂中及氮气保护下,于60~120℃反应6~12小时,生成离子液体所述有机溶剂为苯或甲苯,其用量为5~8ml/g咪唑类化合物。(1) the imidazole compound React with haloalcohol X-(CH 2 ) n -OH at a molar ratio of 1:1 to 1:1.2, in an organic solvent and under the protection of nitrogen, and react at 60-120°C for 6-12 hours to generate an ionic liquid The organic solvent is benzene or toluene, and its dosage is 5-8ml/g imidazole compound.
(2)步骤(1)中所得的离子液体与盐按1∶1.2~1∶1.5的摩尔比,在水相或有机溶剂中,室温搅拌,反应时间为12~48小时。经过与盐的阴离子交换,得到离子液体所用盐为NaBF4,KPF6或CF3COONa。所述有机溶剂为丙酮、乙醇、乙腈或DMF,其用量为10~50ml/g离子液体。(2) The ionic liquid obtained in step (1) and the salt are stirred in an aqueous phase or an organic solvent at room temperature in a molar ratio of 1:1.2 to 1:1.5, and the reaction time is 12 to 48 hours. After anion exchange with salt, the ionic liquid is obtained The salts used were NaBF 4 , KPF 6 or CF 3 COONa. The organic solvent is acetone, ethanol, acetonitrile or DMF, and its dosage is 10-50ml/g ionic liquid.
(3)步骤(2)中得到的离子液体与对甲苯磺酰氯按1∶1~1∶1.2摩尔比,冰水浴下搅拌,反应时间为4~12小时,在有机溶剂和碱性试剂中制得离子液体的对甲苯磺酸酯所述有机溶剂为二氯甲烷或乙腈,用量为6~12ml/g离子液体。碱性试剂为三乙胺或吡啶,用量与对甲苯磺酰氯相同。得到的对甲苯磺酸酯再与4-羟基吡啶在碱的作用下反应,得到含离子液体的吡啶配体 (3) The ionic liquid obtained in the step (2) and p-toluenesulfonyl chloride are in a molar ratio of 1:1 to 1:1.2, stirred under an ice-water bath, and the reaction time is 4 to 12 hours, prepared in an organic solvent and an alkaline reagent p-toluenesulfonate The organic solvent is dichloromethane or acetonitrile, and the dosage is 6-12ml/g ionic liquid. The basic reagent is triethylamine or pyridine, and the dosage is the same as that of p-toluenesulfonyl chloride. The obtained p-toluenesulfonate is then reacted with 4-hydroxypyridine under the action of a base to obtain a pyridine ligand containing an ionic liquid
第二步:合成含吡啶配体的离子液体负载的钌催化剂:The second step: synthesis of ruthenium catalyst supported by ionic liquid containing pyridine ligand:
将1中所得的含离子液体的吡啶配体与与[Ru]按摩尔比5∶1~10∶1,优选摩尔比为8∶1,反应温度为室温,反应时间为1~4小时,在混合有机溶剂中制得含吡啶配体的离子液体负载的钌催化剂和含离子液体的吡啶配体的混合物。所述混合有机溶剂为二氯甲烷或丙酮和二氯甲烷的混合溶剂,优选摩尔比为丙酮∶二氯甲烷=1.2∶1。将此反应混合物抽干溶剂后经有机溶剂纯化处理,得到含吡啶配体的离子液体负载的钌催化剂所述有机溶剂为二氯甲烷、丙酮、正己烷。The pyridine ligand containing the ionic liquid obtained in 1 is mixed with [Ru] in a molar ratio of 5:1 to 10:1, preferably a molar ratio of 8:1, the reaction temperature is room temperature, and the reaction time is 1 to 4 hours. A mixture of the ruthenium catalyst supported by the ionic liquid containing the pyridine ligand and the pyridine ligand containing the ionic liquid is prepared in a mixed organic solvent. The mixed organic solvent is dichloromethane or a mixed solvent of acetone and dichloromethane, and the preferred molar ratio is acetone:dichloromethane=1.2:1. After the reaction mixture is drained of the solvent, it is purified by an organic solvent to obtain a ruthenium catalyst supported by an ionic liquid containing a pyridine ligand Described organic solvent is dichloromethane, acetone, n-hexane.
上述式中R1为BF4 -,PF6 -或CF3COO-,R2为H或甲基(-CH3),n是从2到12的自然数,[Ru]是Grubbs第一代催化剂或Grubbs第二代催化剂。In the above formula, R 1 is BF 4 - , PF 6 - or CF 3 COO - , R 2 is H or methyl (-CH 3 ), n is a natural number from 2 to 12, [Ru] is Grubbs first-generation catalyst Or Grubbs second-generation catalyst.
本发明的方法中,X表示卤素,优选氯和溴。In the process of the present invention, X represents halogen, preferably chlorine and bromine.
本发明的含吡啶配体的离子液体负载的钌催化剂经核磁共振方法检测,证实其为所述的钌催化剂。The ruthenium catalyst supported by the ionic liquid containing the pyridine ligand of the present invention is detected by the nuclear magnetic resonance method, and it is confirmed that it is the ruthenium catalyst.
有益效果:本发明的含吡啶配体的离子液体负载的钌催化剂改善了现有的钌催化剂在极性溶剂中溶解性差的缺点,此催化剂可以溶解在极性溶剂如醇类、丙酮和离子液体中,进而实现在纯离子液体中的开环易位聚合反应,拓展了钌催化剂的应用范围。Beneficial effect: the ruthenium catalyst supported by ionic liquid containing pyridine ligand of the present invention improves the disadvantage of poor solubility of existing ruthenium catalysts in polar solvents, and this catalyst can be dissolved in polar solvents such as alcohols, acetone and ionic liquids In this way, the ring-opening metathesis polymerization reaction in pure ionic liquids is realized, which expands the application range of ruthenium catalysts.
具体实施方式Detailed ways
本发明提供的实施例如下:Embodiments provided by the invention are as follows:
实施例1Example 1
1,2-二甲基-3-羟乙基咪唑氯离子液体(1)的合成Synthesis of 1,2-Dimethyl-3-hydroxyethylimidazolium Chloride Ionic Liquid (1)
向250ml反应瓶中加入1,2-二甲基咪唑(19.2g,200mmol)和氯乙醇(16.1ml,240mmol),用20ml甲苯溶解,110℃反应8小时,停止反应,静置,倒去上层甲苯。再用甲苯洗三次(20ml×3)。向粗产品中加入20ml丙酮,70℃回流搅拌30min,静置,倒去上层溶剂。重复用丙酮洗涤二次,静置,冷却,下层有浅黄色固体析出。将浅黄色粗产品用乙腈重结晶,得到白色晶体,真空干燥得到化合物1(27.5g,产率78%)。1H-NMR(D2O,δ):7.35(d,2H,N-CH=HC-N),4.22(t,2H,N-CH2),3.87(t,2H,CH2-OH),3.74(s,3H,N-CH3),2.56(s,3H,C-CH3);13C-NMR(D2O,δ):146.36(N-C-N),123.76,122.39(HC=CH),61.31(CH2-OH),51.53(N-CH2),36.12(N-CH3),10.53(C-CH3)。Add 1,2-dimethylimidazole (19.2g, 200mmol) and chloroethanol (16.1ml, 240mmol) into a 250ml reaction flask, dissolve in 20ml of toluene, react at 110°C for 8 hours, stop the reaction, let it stand, and pour off the upper layer toluene. Then wash three times with toluene (20ml×3). Add 20ml of acetone to the crude product, stir at reflux at 70°C for 30min, let stand, and pour off the upper solvent. Repeat washing with acetone twice, let it stand, and cool down, and a light yellow solid is precipitated in the lower layer. The light yellow crude product was recrystallized from acetonitrile to obtain white crystals, which were dried in vacuo to obtain compound 1 (27.5 g, yield 78%). 1 H-NMR (D 2 O, δ): 7.35 (d, 2H, N-CH=HC-N), 4.22 (t, 2H, N-CH 2 ), 3.87 (t, 2H, CH 2 -OH) , 3.74 (s, 3H, N-CH 3 ), 2.56 (s, 3H, C-CH 3 ); 13 C-NMR (D 2 O, δ): 146.36 (NCN), 123.76, 122.39 (HC=CH) , 61.31 (CH2 - OH), 51.53 (N- CH2 ), 36.12 (N- CH3 ), 10.53 (C- CH3 ).
实施例2Example 2
1,2-二甲基-3-羟乙基六氟磷酸盐离子液体(2)的合成Synthesis of 1,2-Dimethyl-3-hydroxyethylhexafluorophosphate Ionic Liquid (2)
将KPF6(13.2g,72mmol)溶解在80ml水中,用冰水浴冷却,然后将化合物1(10.6g,60mmol)的50ml水溶液缓慢滴入。滴加完后逐渐升至室温反应12小时,停止反应。脱去溶剂水,得到浅黄色粘稠液体(含有白色固体)。用50ml丙酮溶解,过滤,滤液用无水硫酸钠干燥,脱掉溶剂后得无色粘稠液体,真空干燥,得到化合物2(14.2g,产率83%)。1H-NMR(D2O,δ):7.40(d,2H,HC=CH),4.27(t,2H,N-CH2),3.94(t,2H,CH2-OH),3.80(s,3H,N-CH3),2.62(s,3H,C-CH3);13C-NMR(D2O,δ):146.36(N-C-N),123.76,122.39(HC=CH),61.31(CH2-OH),51.53(N-CH2),36.12(N-CH3),10.53(C-CH3);31P-NMR(D2O,δ):-144.4(PF6 -)。KPF 6 (13.2g, 72mmol) was dissolved in 80ml of water, cooled with an ice-water bath, and then a 50ml aqueous solution of compound 1 (10.6g, 60mmol) was slowly dropped into it. After the dropwise addition, the reaction was gradually raised to room temperature for 12 hours, and the reaction was stopped. The solvent water was removed to obtain a light yellow viscous liquid (containing white solid). Dissolved with 50ml of acetone, filtered, and the filtrate was dried with anhydrous sodium sulfate, and the solvent was removed to obtain a colorless viscous liquid, which was dried in vacuo to obtain compound 2 (14.2g, yield 83%). 1 H-NMR (D 2 O, δ): 7.40 (d, 2H, HC=CH), 4.27 (t, 2H, N-CH 2 ), 3.94 (t, 2H, CH 2 -OH), 3.80 (s , 3H, N-CH 3 ), 2.62 (s, 3H, C-CH 3 ); 13 C-NMR (D 2 O, δ): 146.36 (NCN), 123.76, 122.39 (HC=CH), 61.31 (CH 2 -OH), 51.53 (N-CH 2 ), 36.12 (N-CH 3 ), 10.53 (C-CH 3 ); 31 P-NMR (D 2 O, δ): -144.4 (PF 6 - ).
实施例3Example 3
1,2-二甲基-3-对甲苯磺酸乙酯六氟磷酸盐咪唑离子液体(3)的合成Synthesis of 1,2-dimethyl-3-ethyl p-toluenesulfonate imidazolium ionic liquid (3)
氮气保护下,向250ml Schlenk反应瓶中加入2(5.72g,20mmol),用35ml乙腈溶解,然后加入三乙胺(3.4ml,24mmol),冰水浴冷却。对甲苯磺酰氯(4.58g,24mmol)用25mL乙腈溶解,冰浴条件下滴加。滴加完后,维持0-5℃反应1小时,再升至室温反应10小时,停止反应。过滤,脱掉溶剂,得固体和深色粘稠液,用100ml CH2Cl2溶解,水洗多次后,有机相用无水Na2SO4干燥。脱去CH2Cl2得棕黄色固体,将固体用丙酮∶乙醚=2∶1重结晶得浅黄色固体,真空干燥得到产物4.84g,产率55.5%。1H-NMR(CO(CD3)2,δ):7.76(2H,HC=CHim),7.57(2H,2×CHaryl-C-S),7.51(2H,2×CHaryl-C-CH3),4.68(2H,N-CH2),4.53(2H,CH2-O),3.96(3H,N-CH3),2.76(3H,N-C-CH3),2.48(3H,Caryl-CH3);13C-NMR(CO(CD3)2,δ):146.65(Caryl-CH3),146.49(C2im),133.33(Caryl-S),131.11(2×CHaryl-Caryl-CH3),128.62(2×CHaryl-Caryl-S),123.75(C4im),122.31(C5im),69.01(CH2-O),48.00(N-CH2),35.70(N-CH3),21.54(Caryl-CH3),9.91(C-CH3)。Under nitrogen protection, 2 (5.72g, 20mmol) was added to a 250ml Schlenk reaction flask, dissolved in 35ml of acetonitrile, then triethylamine (3.4ml, 24mmol) was added, cooled in an ice-water bath. p-Toluenesulfonyl chloride (4.58g, 24mmol) was dissolved in 25mL of acetonitrile and added dropwise under ice-bath conditions. After the dropwise addition, the reaction was maintained at 0-5°C for 1 hour, then raised to room temperature for 10 hours, and the reaction was stopped. Filter and remove the solvent to obtain solid and dark viscous liquid, which are dissolved in 100ml CH 2 Cl 2 and washed with water several times, and the organic phase is dried with anhydrous Na 2 SO 4 . The CH 2 Cl 2 was removed to obtain a brown-yellow solid, which was recrystallized from acetone:ether=2:1 to obtain a light-yellow solid, which was dried in vacuo to obtain 4.84 g of the product, with a yield of 55.5%. 1 H-NMR (CO(CD 3 ) 2 , δ): 7.76 (2H, HC=CHim), 7.57 (2H, 2×CH aryl -CS), 7.51 (2H, 2×CH aryl -C-CH 3 ) , 4.68(2H, N-CH 2 ), 4.53(2H, CH 2 -O), 3.96(3H, N-CH 3 ), 2.76(3H, NC-CH 3 ), 2.48(3H, Caryl -CH 3 ); 13 C-NMR (CO(CD 3 ) 2 , δ): 146.65 (C aryl -CH 3 ), 146.49 (C 2 im), 133.33 (C aryl -S), 131.11 (2×CH aryl -C aryl -CH 3 ), 128.62 (2×CH aryl -C aryl -S), 123.75 (C 4 im), 122.31 (C 5 im), 69.01 (CH 2 -O), 48.00 (N-CH 2 ), 35.70 ( N-CH 3 ), 21.54 (C aryl -CH 3 ), 9.91 (C-CH 3 ).
实施例4Example 4
1,2-二甲基-3-乙氧基吡啶六氟磷酸盐咪唑离子液体(4)的合成Synthesis of 1,2-Dimethyl-3-ethoxypyridine Hexafluorophosphate Imidazolium Ionic Liquid (4)
氮气保护下,向100ml Schlenk反应瓶中加入4-羟基吡啶(0.58g,6.05mmol)和碳酸钾(1.25g,9.08mmol),用20ml DMF溶解,升温至80℃反应5小时。然后滴加3(2.20g,5.00mmol)的DMF(10ml)溶液,80℃搅拌4d,停止反应,体系为棕褐色。冷却过滤,除去溶剂,加入30ml丙酮搅拌,过滤除去不溶物,脱去丙酮,剩余褐色固体用丙酮∶乙酸乙酯=1∶1重结晶,得淡黄色晶体,真空干燥得到产物0.78g,产率43%。1H-NMR(CO(CD3)2,δ):8.40(2H,2×CHPy-N),7.75-7.63(2H,CH=CHim),6.95(2H,2×CHPy-C-O),4.83(2H,N-CH2),4.57(2H,CH2-O),3.97(3H,N-CH3)),2.95(3H,N-C-CH3);13C-NMR:(CO(CD3)2,δ):165.46(CPy-O),152.63(2×CHPy-N),147.63(C2im),124.20(C4im),123.21(C5im),111.71(2×CHPy-C-O),67.62(CH2-O),49.02(N-CH2),36.27(N-CH3),10.70(C-CH3);EA(%):C39.73,H4.61,N11.73(calc:C39.68,H4.44,N11.57)。Under nitrogen protection, 4-hydroxypyridine (0.58g, 6.05mmol) and potassium carbonate (1.25g, 9.08mmol) were added into a 100ml Schlenk reaction flask, dissolved in 20ml DMF, and heated to 80°C for 5 hours. Then a DMF (10ml) solution of 3 (2.20g, 5.00mmol) was added dropwise, stirred at 80°C for 4d, the reaction was stopped, and the system was brown. Cool and filter, remove the solvent, add 30ml of acetone and stir, filter to remove insoluble matter, remove the acetone, and recrystallize the remaining brown solid with acetone:ethyl acetate=1:1 to obtain light yellow crystals, which are dried in vacuo to obtain 0.78g of the product. 43%. 1 H-NMR (CO(CD 3 ) 2 , δ): 8.40 (2H, 2×CH Py -N), 7.75-7.63 (2H, CH=CHim), 6.95 (2H, 2×CH Py -CO), 4.83 (2H, N-CH 2 ), 4.57 (2H, CH 2 -O), 3.97 (3H, N-CH 3 )), 2.95 (3H, NC-CH 3 ); 13 C-NMR: (CO(CD 3 ) 2 , δ): 165.46 (C Py -O), 152.63 (2×CH Py -N), 147.63 (C 2 im), 124.20 (C 4 im), 123.21 (C 5 im), 111.71 (2× CH Py -CO), 67.62 (CH 2 -O), 49.02 (N-CH 2 ), 36.27 (N-CH 3 ), 10.70 (C-CH 3 ); EA (%): C39.73, H4.61 , N11.73 (calc: C39.68, H4.44, N11.57).
实施例5Example 5
含吡啶配体的离子液体负载钌催化剂的合成(5)Synthesis of Ruthenium Catalysts Supported by Ionic Liquids Containing Pyridine Ligands(5)
高纯氮保护下,向10mL Schlenk管中加入配体4(145mg,0.40mmol),向另一支管中加入第二代Grubbs催化剂(44.2mg,0.050mmol),两管分别抽真空充氮气,置换三次。用1.2ml干燥脱氧的丙酮溶解配体4,用1ml干燥的CH2Cl2溶解催化剂,两支反应管经液氮冷冻-抽真空-充氮气-融化后,在氮气氛围下将催化剂溶液滴加到配体溶液中。常温下搅拌,体系逐渐由红棕色变墨绿色,反应4小时,停止反应。氮气保护下减压脱掉溶剂,得绿色固体。加入1ml CH2Cl2,溶液为黄绿色,不溶固体为绿色,静置,吸出上层清液,弃之。剩余固体分别用少许CH2Cl2和己烷洗涤一次,减压干燥得绿色固体(该固体为配体4和催化剂的混合物)。1H-NMR(CO(CD3)2,δ):16.27(1H,Ru=CH-Ph),9.36(1H,CH-Ru),7.97~8.11(CHPy),7.73~7.62(CHim=CHim),7.43~7.35(CHaryl),6.5(CHPy),5.94~5.91(CH2),5.54~5.51(CH2),4.80(CH2),4.54(CH2),4.00(N-CH3),2.97(C-CH3),2.88~2.71(CH3);13C-NMR:(CO(CD3)2,δ):212.64(N-CH-Ru),165.01(CPy-O),152.11(2×CHpy-N),146.63(C2im),141.64,138.57,130.35,129.94,128.87,124.39(C4im),124.11,123.59,123.46,122.53(C5im),118.57,111.34(2×CHPy-C-O),110.92,69.27,67.17(CH2-O),54.91,48.31(N-CH2),35.65(N-CH3),20.21,18.85,10.85(C-CH3),10.08;31P-NMR(CO(CD3)2,δ):-143.3(PF6 -);ICP:催化剂的含量为14wt%。Under the protection of high-purity nitrogen, ligand 4 (145 mg, 0.40 mmol) was added to a 10 mL Schlenk tube, and the second-generation Grubbs catalyst (44.2 mg, 0.050 mmol) was added to another tube. three times. Dissolve the ligand 4 with 1.2ml of dry deoxygenated acetone, dissolve the catalyst with 1ml of dry CH 2 Cl 2 , freeze the two reaction tubes with liquid nitrogen-vacuumize-fill with nitrogen-thaw, add the catalyst solution dropwise under nitrogen atmosphere into the ligand solution. Stirring at room temperature, the system gradually changed from reddish brown to dark green, reacted for 4 hours, and stopped the reaction. Under nitrogen protection, the solvent was removed under reduced pressure to obtain a green solid. Add 1ml CH 2 Cl 2 , the solution is yellow-green, and the insoluble solid is green, let stand, suck out the supernatant, and discard it. The remaining solid was washed once with a little CH 2 Cl 2 and hexane, and dried under reduced pressure to obtain a green solid (the solid is a mixture of ligand 4 and catalyst). 1 H-NMR (CO(CD 3 ) 2 , δ): 16.27 (1H, Ru=CH-Ph), 9.36 (1H, CH-Ru), 7.97-8.11 (CH Py ), 7.73-7.62 (CHim=CHim ), 7.43~7.35 (CH aryl ), 6.5 (CH Py ), 5.94~5.91 (CH 2 ), 5.54~5.51 (CH 2 ), 4.80 (CH 2 ), 4.54 (CH 2 ), 4.00 (N-CH 3 ), 2.97 (C-CH 3 ), 2.88~2.71 (CH 3 ); 13 C-NMR: (CO(CD 3 ) 2 , δ): 212.64 (N-CH-Ru), 165.01 (C Py -O) , 152.11 (2×CH py -N), 146.63 (C 2 im), 141.64, 138.57, 130.35, 129.94, 128.87, 124.39 (C 4 im), 124.11, 123.59, 123.46, 122.53 (C 5 im), 118.57, 111.34 (2×CH Py -CO), 110.92, 69.27, 67.17 (CH 2 -O), 54.91, 48.31 (N-CH 2 ), 35.65 (N-CH 3 ), 20.21, 18.85, 10.85 (C-CH 3 ), 10.08; 31 P-NMR (CO(CD 3 ) 2 , δ): -143.3 (PF 6 - ); ICP: The catalyst content is 14 wt%.
实施例6Example 6
1,2-二甲基-3-十二烷基醇咪唑溴离子液体(6)的合成Synthesis of 1,2-Dimethyl-3-dodecyl imidazolium bromide ionic liquid (6)
向250ml反应瓶中加入1,2-二甲基咪唑(9.6g,100mmol)和12-溴代十二醇(29.2g,110mmol),用40ml甲苯溶解,70℃反应8小时,停止反应,静置,倒去上层甲苯。再用甲苯洗三次(30ml×3)。向粗产品中加入40ml丙酮,70℃回流搅拌30min,静置,倒去上层溶剂。重复用丙酮洗涤二次,静置,冷却,下层有浅黄色固体析出。将浅黄色粗产品用乙腈重结晶,得到白色晶体,真空干燥得到化合物6(32.2g,产率89%)。1H-NMR(D2O,δ):7.35(d,2H,N-CH=HC-N),4.04(t,2H,N-CH2),3.50(t,2H,CH2-OH),3.74(s,3H,N-CH3),2.56(s,3H,C-CH3),1.74(t,2H,N-CH2-CH2),1.53(t,2H,CH2-CH2-OH),1.43(t,2H,CH2-(CH2)2-OH),1.29(m,12H,N-(CH2)2-CH2);13C-NMR(D2O,δ):146.36(N-C-N),123.76,122.39(HC=CH),61.31(CH2-OH),51.53(N-CH2),36.12(N-CH3),32.2(CH2-CH2-OH),30.4(N-CH2-CH2),27.1(N-(CH2)2-CH2),29.3(N-(CH2)3-CH2),25.6(CH2-(CH2)2-OH)),10.53(C-CH3)。Add 1,2-dimethylimidazole (9.6g, 100mmol) and 12-bromododecanol (29.2g, 110mmol) into the 250ml reaction flask, dissolve with 40ml toluene, react at 70°C for 8 hours, stop the reaction, and Set aside, pour off the upper layer of toluene. Then wash three times with toluene (30ml×3). Add 40ml of acetone to the crude product, stir at reflux at 70°C for 30min, let stand, and pour off the upper solvent. Repeat washing with acetone twice, let it stand, and cool down, and a light yellow solid is precipitated in the lower layer. The light yellow crude product was recrystallized from acetonitrile to obtain white crystals, which were dried in vacuo to obtain compound 6 (32.2 g, yield 89%). 1 H-NMR (D 2 O, δ): 7.35 (d, 2H, N-CH=HC-N), 4.04 (t, 2H, N-CH 2 ), 3.50 (t, 2H, CH 2 -OH) , 3.74(s, 3H, N-CH 3 ), 2.56(s, 3H, C-CH 3 ), 1.74(t, 2H, N-CH 2 -CH 2 ), 1.53(t, 2H, CH 2 -CH 2 -OH), 1.43 (t, 2H, CH 2 -(CH 2 ) 2 -OH), 1.29 (m, 12H, N-(CH 2 ) 2 -CH 2 ); 13 C-NMR (D 2 O, δ): 146.36 (NCN), 123.76, 122.39 (HC=CH), 61.31 (CH 2 -OH), 51.53 (N-CH 2 ), 36.12 (N-CH 3 ), 32.2 (CH 2 -CH 2 -OH ), 30.4(N-CH 2 -CH 2 ), 27.1(N-(CH 2 ) 2 -CH 2 ), 29.3(N-(CH 2 ) 3 -CH 2 ), 25.6(CH 2 -(CH 2 ) 2 -OH)), 10.53 (C- CH3 ).
实施例7Example 7
1,2-二甲基-3-十二烷基醇六氟磷酸盐离子液体(7)的合成Synthesis of 1,2-Dimethyl-3-dodecanol Hexafluorophosphate Ionic Liquid (7)
将KPF6(13.2g,72mmol)溶解在80ml水中,用冰水浴冷却,然后将化合物6(13.2g,60mmol)的150ml水溶液缓慢滴入。滴加完后逐渐升至室温反应48小时,停止反应。脱去溶剂水,得到白色固体。用50ml CH2Cl2溶解,过滤,滤液用水洗涤(30ml×4),有机相用无水硫酸钠干燥,脱掉溶剂后得白色固体,真空干燥,得到化合物7(21.2g,产率83%)。1H-NMR(DMSO,δ):7.35(d,2H,N-CH=HC-N),4.04(t,2H,N-CH2),3.50(t,2H,CH2-OH),3.74(s,3H,N-CH3),2.56(s,3H,C-CH3),1.74(t,2H,N-CH2-CH2),1.53(t,2H,CH2-CH2-OH),1.43(t,2H,CH2-(CH2)2-OH),1.29(m,12H,N-(CH2)2-CH2);13C-NMR(DMSO,δ):146.36(N-C-N),123.76,122.39(HC=CH),61.31(CH2-OH),51.53(N-CH2),36.12(N-CH3),32.2(CH2-CH2-OH,30.4(N-CH2-CH2),27.1(N-(CH2)2-CH2),29.3(N-(CH2)3-CH2),25.6(CH2-(CH2)2-OH)),10.53(C-CH3)。KPF 6 (13.2g, 72mmol) was dissolved in 80ml of water, cooled with an ice-water bath, and then a 150ml aqueous solution of compound 6 (13.2g, 60mmol) was slowly added dropwise. After the dropwise addition, the reaction was gradually raised to room temperature for 48 hours, and the reaction was stopped. The solvent water was removed to obtain a white solid. Dissolved with 50ml CH 2 Cl 2 , filtered, the filtrate was washed with water (30ml×4), the organic phase was dried with anhydrous sodium sulfate, a white solid was obtained after removing the solvent, and dried in vacuo to obtain compound 7 (21.2g, yield 83% ). 1 H-NMR (DMSO, δ): 7.35 (d, 2H, N-CH=HC-N), 4.04 (t, 2H, N-CH 2 ), 3.50 (t, 2H, CH 2 -OH), 3.74 (s, 3H, N-CH 3 ), 2.56 (s, 3H, C-CH 3 ), 1.74 (t, 2H, N-CH 2 -CH 2 ), 1.53 (t, 2H, CH 2 -CH 2 - OH), 1.43 (t, 2H, CH 2 -(CH 2 ) 2 -OH), 1.29 (m, 12H, N-(CH 2 ) 2 -CH 2 ); 13 C-NMR (DMSO, δ): 146.36 (NCN), 123.76, 122.39 (HC=CH), 61.31 (CH 2 -OH), 51.53 (N-CH 2 ), 36.12 (N-CH 3 ), 32.2 (CH 2 -CH 2 -OH, 30.4 (N -CH 2 -CH 2 ), 27.1(N-(CH 2 ) 2 -CH 2 ), 29.3(N-(CH 2 ) 3 -CH 2 ), 25.6(CH 2 -(CH 2 ) 2 -OH)) , 10.53 (C—CH 3 ).
实施例8Example 8
1,2-二甲基-3-对甲苯磺酸十二烷基酯六氟磷酸盐咪唑离子液体(8)的合成Synthesis of 1,2-Dimethyl-3-dodecyl p-toluenesulfonate Imidazolium Hexafluorophosphate Ionic Liquid (8)
氮气保护下,向250ml Schlenk反应瓶中加入7(8.53g,20mmol),用35ml乙腈溶解,然后加入三乙胺(3.4ml,24mmol),冰水浴冷却。对甲苯磺酰氯(4.58g,24mmol)用25mL乙腈溶解,冰浴条件下滴加。滴加完后,维持0-5℃反应1小时,再升至室温反应24小时,停止反应。过滤,脱掉溶剂,得固体和深色粘稠液,用100ml CH2Cl2溶解,水洗多次后,有机相用无水Na2SO4干燥。脱去CH2Cl2得棕黄色固体,将固体用丙酮∶乙醚=2∶1重结晶得浅黄色固体,真空干燥得到产物6.40g,产率55.5%。1H-NMR(DMSO,δ):7.35(N-CH=HC-N),7.17(2×CHaryl-C-S),7.11(2×CHaryl-C-CH3),4.04(N-CH2),3.50(CH2-OH),3.74(3H,N-CH3),2.56(3H,C-CH3),2.34(3H,Caryl-CH3),1.74(2H,N-CH2-CH2),1.53(2H,CH2-CH2-OH),1.43(2H,CH2-(CH2)2-OH),1.29(12H,N-(CH2)2-CH2);13C-NMR(DMSO,δ):146.65(Caryl-CH3),146.36(N-C-N),135.33(Caryl-S),131.11(2×CHaryl-Caryl-CH3),128.62(2×CHaryl-Caryl-S),123.76,122.39(HC=CH),61.31(CH2-OH),51.53(N-CH2),36.12(N-CH3),32.2(CH2-CH2-OH),30.4(N-CH2-CH2),27.1(N-(CH2)2-CH2),29.3(N-(CH2)3-CH2),25.6(CH2-(CH2)2-OH),21.34(Caryl-CH3),10.53(C-CH3)。Under nitrogen protection, 7 (8.53g, 20mmol) was added to a 250ml Schlenk reaction flask, dissolved in 35ml of acetonitrile, then triethylamine (3.4ml, 24mmol) was added, cooled in an ice-water bath. p-Toluenesulfonyl chloride (4.58g, 24mmol) was dissolved in 25mL of acetonitrile and added dropwise under ice-bath conditions. After the dropwise addition, the reaction was maintained at 0-5°C for 1 hour, then raised to room temperature for 24 hours, and the reaction was stopped. Filter and remove the solvent to obtain solid and dark viscous liquid, which are dissolved in 100ml CH 2 Cl 2 and washed with water several times, and the organic phase is dried with anhydrous Na 2 SO 4 . The CH 2 Cl 2 was removed to obtain a brownish yellow solid, which was recrystallized from acetone:ether = 2:1 to obtain a light yellow solid, which was dried in vacuo to obtain 6.40 g of the product, with a yield of 55.5%. 1 H-NMR (DMSO, δ): 7.35 (N-CH=HC-N), 7.17 (2×CH aryl -CS), 7.11 (2×CH aryl -C-CH 3 ), 4.04 (N-CH 2 ), 3.50 (CH 2 -OH), 3.74 (3H, N-CH 3 ), 2.56 (3H, C-CH 3 ), 2.34 (3H, Caryl -CH 3 ), 1.74 (2H, N-CH 2 - CH 2 ), 1.53 (2H, CH 2 -CH 2 -OH), 1.43 (2H, CH 2 -(CH 2 ) 2 -OH), 1.29 (12H, N-(CH 2 ) 2 -CH 2 ); 13 C-NMR (DMSO, δ): 146.65 (C aryl -CH 3 ), 146.36 (NCN), 135.33 (C aryl -S), 131.11 (2×CH aryl -C aryl -CH 3 ), 128.62 (2×C Haryl -C aryl -S), 123.76, 122.39 (HC=CH), 61.31 (CH 2 -OH), 51.53 (N-CH 2 ), 36.12 (N-CH 3 ), 32.2 (CH 2 -CH 2 -OH ), 30.4(N-CH 2 -CH 2 ), 27.1(N-(CH 2 ) 2 -CH 2 ), 29.3(N-(CH 2 ) 3 -CH 2 ), 25.6(CH 2 -(CH 2 ) 2-OH), 21.34 (C aryl -CH 3 ), 10.53 (C-CH 3 ).
实施例9Example 9
1,2-二甲基-3-十二烷氧基吡啶六氟磷酸盐咪唑离子液体(9)的合成Synthesis of 1,2-Dimethyl-3-dodecyloxypyridinium Hexafluorophosphate Imidazolium Ionic Liquid (9)
氮气保护下,向100ml Schlenk反应瓶中加入4-羟基吡啶(0.58g,6.05mmol)和碳酸钾(1.25g,9.08mmol),用20ml DMF溶解,升温至80℃反应5小时。然后滴加8(2.91g,5.00mmol)的DMF(10ml)溶液,80℃搅拌4d,停止反应,体系为棕褐色。冷却过滤,除去溶剂,加入30ml丙酮搅拌,过滤除去不溶物,脱去丙酮,剩余褐色固体用丙酮∶乙酸乙酯=1∶1重结晶,得淡黄色晶体,真空干燥得到产物1.07g,产率43%。1H-NMR(DMSO,δ):8.25(2H,2×CHPy-N),7.35(2H,N-CH=HC-N),6.85(2H,2×CHPy-C-O),4.04(2H,N-CH2),3.50(2H,CH2-OH),3.74(3H,N-CH3),2.56(3H,C-CH3),1.74(2H,N-CH2-CH2),1.53(2H,CH2-CH2-OH),1.43(2H,CH2-(CH2)2-OH),1.29(12H,N-(CH2)2-CH2);13C-NMR(DMSO,δ):156.2(CPy-O),150.7(2×CHPy-N),146.36(N-C-N),123.76,122.39(HC=CH),100.71(2×CHPy-C-O),61.31(CH2-OH),51.53(N-CH2),36.12(N-CH3),32.2(CH2-CH2-OH),30.4(N-CH2-CH2),27.1(N-(CH2)2-CH2),29.3(N-(CH2)3-CH2),25.6(CH2-(CH2)2-OH),10.53(C-CH3)。Under nitrogen protection, 4-hydroxypyridine (0.58g, 6.05mmol) and potassium carbonate (1.25g, 9.08mmol) were added into a 100ml Schlenk reaction flask, dissolved in 20ml DMF, and heated to 80°C for 5 hours. Then a DMF (10ml) solution of 8 (2.91g, 5.00mmol) was added dropwise, stirred at 80°C for 4d, the reaction was stopped, and the system was brown. Cool and filter, remove the solvent, add 30ml of acetone and stir, filter to remove insoluble matter, remove the acetone, and recrystallize the remaining brown solid with acetone:ethyl acetate=1:1 to obtain light yellow crystals, which are dried in vacuo to obtain 1.07g of the product, the yield 43%. 1 H-NMR (DMSO, δ): 8.25 (2H, 2×CH Py -N), 7.35 (2H, N-CH=HC-N), 6.85 (2H, 2×CH Py- CO), 4.04 (2H , N-CH 2 ), 3.50 (2H, CH 2 -OH), 3.74 (3H, N-CH 3 ), 2.56 (3H, C-CH 3 ), 1.74 (2H, N-CH 2 -CH 2 ), 1.53(2H, CH2 - CH2- OH), 1.43(2H, CH2- ( CH2 ) 2 -OH), 1.29(12H, N-( CH2 ) 2 - CH2 ); 13C -NMR( DMSO, δ): 156.2 (C Py -O), 150.7 (2×CH Py -N), 146.36 (NCN), 123.76, 122.39 (HC=CH), 100.71 (2×CH Py -CO), 61.31 (CH 2 -OH), 51.53(N-CH 2 ), 36.12(N-CH 3 ), 32.2(CH 2 -CH 2 -OH), 30.4(N-CH 2 -CH 2 ), 27.1(N-(CH 2 ) 2 -CH 2 ), 29.3 (N-(CH 2 ) 3 -CH 2 ), 25.6 (CH 2 -(CH 2 ) 2 -OH), 10.53 (C-CH 3 ).
实施例10Example 10
含吡啶配体的离子液体负载钌催化剂的合成(10)Synthesis of Ruthenium Catalysts Supported by Ionic Liquids Containing Pyridine Ligands(10)
高纯氮保护下,向10ml Schlenk管中加入配体9(200mg,0.40mmol),向另一支管中加入第二代Grubbs催化剂(44.2mg,0.050mmol),两管分别抽真空充氮气,置换三次。用1.2ml干燥脱氧的丙酮溶解配体9,用1ml干燥的CH2Cl2溶解催化剂,两支反应管经液氮冷冻-抽真空-充氮气-融化后,在氮气氛围下将催化剂溶液滴加到配体溶液中。常温下搅拌,体系逐渐由红棕色变墨绿色,反应4小时,停止反应。氮气保护下减压脱掉溶剂,得绿色固体。加入1ml CH2Cl2,溶液为黄绿色,不溶固体为绿色,静置,吸出上层清液,弃之。剩余固体分别用少许CH2Cl2和己烷洗涤一次,减压干燥得绿色固体(该固体为配体9和催化剂的混合物)。1H-NMR(DMSO,δ):16.27(1H,Ru=CH-Ph),9.43(1H,CH-Ru),7.73~7.62(CHim=CHim),7.97~8.25(CHPy),7.43~7.35(CHaryl),6.85(CHPy),4.04(N-CH2),3.50(CH2-OH),3.94(N-CH3),2.88~2.71(CH3),2.56(3H,C-CH3),1.74(N-CH2-CH2),1.53(CH2-CH2-OH),1.43(CH2-(CH2)2-OH),1.29(N-(CH2)2-CH2);13C-NMR(DMSO,δ):212.64(N-CH-Ru),165.7(CPy-O),146.36(N-C-N),150.11(2×CHPy-N),123.76,122.39(HC=CH),100.74(2×CHPy-C-O),61.31(CH2-OH),51.53(N-CH2),36.12(N-CH3),32.2(CH2-CH2-OH),30.4(N-CH2-CH2),27.1(N-(CH2)2-CH2),29.3(N-(CH2)3-CH2),25.6(CH2-(CH2)2-OH),10.53(C-CH3)。31P-NMR(CO(CD3)2,δ):-143.3(PF6 -)。Under the protection of high-purity nitrogen, add ligand 9 (200mg, 0.40mmol) to the 10ml Schlenk tube, add the second-generation Grubbs catalyst (44.2mg, 0.050mmol) to the other branch tube, and vacuumize and fill the two tubes with nitrogen respectively. three times. Dissolve the ligand 9 with 1.2ml of dry deoxygenated acetone, dissolve the catalyst with 1ml of dry CH 2 Cl 2 , freeze the two reaction tubes with liquid nitrogen-vacuumize-fill with nitrogen-thaw, add the catalyst solution dropwise under nitrogen atmosphere into the ligand solution. Stirring at room temperature, the system gradually changed from reddish brown to dark green, reacted for 4 hours, and stopped the reaction. Under nitrogen protection, the solvent was removed under reduced pressure to obtain a green solid. Add 1ml CH 2 Cl 2 , the solution is yellow-green, and the insoluble solid is green, let stand, suck out the supernatant, and discard it. The remaining solid was washed once with a little CH 2 Cl 2 and hexane, and dried under reduced pressure to obtain a green solid (the solid is a mixture of ligand 9 and catalyst). 1 H-NMR (DMSO, δ): 16.27 (1H, Ru=CH-Ph), 9.43 (1H, CH-Ru), 7.73-7.62 (CHim=CHim), 7.97-8.25 (CH Py ), 7.43-7.35 (CH aryl ), 6.85 (CH Py ), 4.04 (N-CH 2 ), 3.50 (CH 2 -OH), 3.94 (N-CH 3 ), 2.88~2.71 (CH 3 ), 2.56 (3H, C-CH 3 ), 1.74(N-CH 2 -CH 2 ), 1.53(CH 2 -CH 2 -OH), 1.43(CH 2 -(CH 2 ) 2 -OH), 1.29(N-(CH 2 ) 2 -CH 2 ); 13 C-NMR (DMSO, δ): 212.64 (N-CH-Ru), 165.7 (C Py -O), 146.36 (NCN), 150.11 (2×CH Py -N), 123.76, 122.39 (HC =CH), 100.74 (2×CH Py -CO), 61.31 (CH 2 -OH), 51.53 (N-CH 2 ), 36.12 (N-CH 3 ), 32.2 (CH 2 -CH 2 -OH), 30.4 (N-CH 2 -CH 2 ), 27.1(N-(CH 2 ) 2 -CH 2 ), 29.3(N-(CH 2 ) 3 -CH 2 ), 25.6(CH 2 -(CH 2 ) 2 -OH ), 10.53 (C—CH 3 ). 31 P-NMR (CO(CD 3 ) 2 , δ): -143.3 (PF 6 - ).
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007100469902A CN101138741A (en) | 2007-10-12 | 2007-10-12 | A kind of ruthenium catalyst supported by ionic liquid containing pyridine ligand and its preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007100469902A CN101138741A (en) | 2007-10-12 | 2007-10-12 | A kind of ruthenium catalyst supported by ionic liquid containing pyridine ligand and its preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101138741A true CN101138741A (en) | 2008-03-12 |
Family
ID=39190942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007100469902A Pending CN101138741A (en) | 2007-10-12 | 2007-10-12 | A kind of ruthenium catalyst supported by ionic liquid containing pyridine ligand and its preparation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101138741A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101961661B (en) * | 2009-07-22 | 2012-08-08 | 中国石油天然气股份有限公司 | Organic metal catalyst for preparing cyclohexene by benzene hydrogenation and preparation method and application thereof |
CN102671709A (en) * | 2012-04-28 | 2012-09-19 | 温州大学 | Supported type acidic ionic liquid catalyst and application thereof |
CN102690291A (en) * | 2012-01-17 | 2012-09-26 | 青岛科技大学 | Imidazole ionic liquid supported chiral phosphine ligands and preparation method thereof |
CN102755909A (en) * | 2011-04-28 | 2012-10-31 | 中国石油天然气股份有限公司 | Catalyst for preparing cyclohexane by benzene hydrogenation and preparation method thereof |
JP2016003182A (en) * | 2014-06-13 | 2016-01-12 | トヨタ紡織株式会社 | New ionic liquid, and method and apparatus for absorbing gas |
CN111957344A (en) * | 2020-08-31 | 2020-11-20 | 郑州中科新兴产业技术研究院 | Ionic liquid modified oxygen reduction reaction catalyst and preparation method thereof |
-
2007
- 2007-10-12 CN CNA2007100469902A patent/CN101138741A/en active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101961661B (en) * | 2009-07-22 | 2012-08-08 | 中国石油天然气股份有限公司 | Organic metal catalyst for preparing cyclohexene by benzene hydrogenation and preparation method and application thereof |
CN102755909A (en) * | 2011-04-28 | 2012-10-31 | 中国石油天然气股份有限公司 | Catalyst for preparing cyclohexane by benzene hydrogenation and preparation method thereof |
CN102755909B (en) * | 2011-04-28 | 2014-08-06 | 中国石油天然气股份有限公司 | Catalyst for preparing cyclohexane by benzene hydrogenation and preparation method thereof |
CN102690291A (en) * | 2012-01-17 | 2012-09-26 | 青岛科技大学 | Imidazole ionic liquid supported chiral phosphine ligands and preparation method thereof |
CN102690291B (en) * | 2012-01-17 | 2014-07-30 | 青岛科技大学 | Imidazole ionic liquid supported chiral phosphine ligands and preparation method thereof |
CN102671709A (en) * | 2012-04-28 | 2012-09-19 | 温州大学 | Supported type acidic ionic liquid catalyst and application thereof |
JP2016003182A (en) * | 2014-06-13 | 2016-01-12 | トヨタ紡織株式会社 | New ionic liquid, and method and apparatus for absorbing gas |
CN111957344A (en) * | 2020-08-31 | 2020-11-20 | 郑州中科新兴产业技术研究院 | Ionic liquid modified oxygen reduction reaction catalyst and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101138741A (en) | A kind of ruthenium catalyst supported by ionic liquid containing pyridine ligand and its preparation | |
CN107573370A (en) | The method that supported copper ion chitosan microball catalysis prepares organoboron compound and β hydroxy compounds | |
CN103265420B (en) | A kind of preparation method of aromatic diketone compound | |
CN103012361A (en) | Supramolecular polymer material constructed by doubly bridging sulfonated calixarenes and preparation thereof | |
CN111187152B (en) | A kind of method for catalyzing and synthesizing pseudo-ionone by alkaline immobilized ionic liquid | |
JP2009023996A (en) | Bipyridine compound, transition metal complex and method for producing conjugated aromatic compound using the complex | |
JP2004517042A (en) | Process for producing olefin-substituted aromatic or heteroaromatic | |
JP2009067779A (en) | Transition metal complex and method for producing conjugated aromatic compound using the complex | |
CH641671A5 (en) | PROCESS FOR THE PREPARATION OF 2- (6'-METHOXY-2'-NAFTIL) -PROPIONIC ACID. | |
CN106749411B (en) | A kind of o-phenanthroline tetradentate ligands and the preparation method and application thereof | |
CN111018678B (en) | Preparation method of high-purity 3-phenoxy bromopropane | |
CN108218798A (en) | The preparation method of Apabetalone | |
CN108864173B (en) | Process for converting substituted sodium aryl sulfinate to aryl tri-n-butyl tin | |
CN102049301A (en) | High-efficiency ionic liquid and cross-linked polystyrene-supported palladium catalyst and application thereof | |
CN110790689A (en) | A kind of synthetic method of 1,1-difluoro-2-isonitrile-ethylphenyl sulfone compounds | |
CN112028874B (en) | Synthesis method of eritinib | |
CN107915653A (en) | Catalysis ester and amine carry out the method that reaction prepares acid amides | |
CN111662147A (en) | Process for preparing diynes and analogues thereof | |
CN101712697A (en) | Ferrocene phosphinimine ligand containing imidazole salt group, preparation thereof and application in catalyzing asymmetric allyl substitution reaction | |
CN102626655B (en) | Aldol reaction catalyst and preparation method and application thereof | |
WO2019119516A1 (en) | Tetramethylspiroindene skeleton-based bisoxazoline ligand compound, intermediate thereof, preparation method therefor, and use thereof | |
CN116144034B (en) | Metallic triangular supramolecules with near-infrared fluorescence, preparation methods and applications | |
CN115353468B (en) | A kind of preparation method of p-toluenesulfonyloxy substituted tert-butyl oligoethylene glycol propionate | |
CN114805800B (en) | A kind of preparation method and application of N-sulfonamide polymer | |
CN103342810A (en) | Polyethylene glycol functionalized three-arm star-shaped ionic liquid and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |